Production of nitric oxide by rat alveolar macrophages stimulated by Cryptococcus neoformans or Aspergillus fumigatus

Medical Mycology

Volumn 37, Issue 3, 1999, Pages 151-157

  Gross, Norma T ^a,b,c   Nessa, K ^b   Camner, P ^b   Jarstrand, C ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSIDAD DE COSTA RICA   (Costa Rica)

Author keywords

Alveolar macrophages; Aspergillus fumigatus; Cryptococcus neoformans; Nitrite

Indexed keywords

GAMMA INTERFERON; NITRIC OXIDE; SILICON DIOXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPERGILLUS FUMIGATUS; CONTROLLED STUDY; CORRELATION FUNCTION; CRYPTOCOCCUS NEOFORMANS; FUNGICIDAL ACTIVITY; LUNG ALVEOLUS MACROPHAGE; MALE; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; RAT;

ANIMALS; ASPERGILLUS FUMIGATUS; CRYPTOCOCCUS NEOFORMANS; INTERFERON TYPE II; MACROPHAGES, ALVEOLAR; MALE; NITRIC OXIDE; PHAGOCYTOSIS; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; ASPERGILLUS FUMIGATUS; FILOBASIDIELLA NEOFORMANS; FUNGI;

EID: 0032794036     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-280X.1999.00209.x     Document Type: Article

References (26)

1. Anaissie E. Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clin Infect Dis 1992; 14 (Suppl 1): 43-53.
2. Dupont B, Graybill JR, Armstrong D, et al. Fungal infections in AIDS patients. J Med Vet Mycol 1992; 30 (Suppl 1): 19-28.
3. Dubois RM. The alveolar macrophages. Thorax 1985; 40: 321-327.
4. Nathan CF, Hibbs JB Jr. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 1991; 3: 65-70.
5. Sherman MP, Loro ML, Wong VZ, Tashkin DP. Cytokine-and Pneumocystis carinii-induced L-arginine oxidation by murine and human pulmonary alveolar macrophages. J Protozool 1991; 38: 234-236.
6. Jorens PG, Van Overveld FJ, Bult H, Vermeire PA, Herman AG. L-arginine-dependent production of nitrogen oxides by rat pulmonary macrophages. Eur J Pharmacol 1991; 200: 205-209.
7. Nicholson S, Bonecini-Almeida MG, Lapa e Silva JR, et al. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J Exp Med 1996; 183: 2293-2302.
8. Lovchik JA, Lyons CR, Lipscomb MF. A role for gamma interferon-induced nitric oxide in pulmonary clearance of Cryptococcus neoformans. Am J Respir Cell Mol Biol 1995; 13: 116-124.
9. Goldman D, Cho Y, Zhao ML, Casadevall A, Lee SC. Expression of inducible nitric oxide synthase in rat pulmonary Cryptococcus neoformans granulomas. Am J Pathol 1996; 148: 1275-1282.
10. Taramelli D, Malabarba MG, Sala G, Basilico N, Cocuzza G. Production of cytokines by alveolar and peritoneal macrophages stimulated by Aspergillus fumigatus conidia or hyphae. J Med Vet Mycol 1996; 34: 49-56.
11. Cameron ML, Granger DL, Weinberg JB, Kozumbo WJ, Koren HS. Human alveolar and peritoneal macrophages mediate fungistasis independently of L-arginine oxidation to nitrite or nitrate. Am Rev Respir Dis 1990; 142: 1313-1319.
12. Michaliszyn E, Sénéchal S, Martel P, de Repentigny L. Lack of involvement of nitric oxide in killing of Aspergillus fumigatus conidia by pulmonary alveolar macrophages. Infect Immun 1995; 63: 2075-2078.
13. Nessa K, Jarstrand C, Johansson A, Camner P. In vitro interaction of alveolar macrophages and Aspergillus fumigatus. Environ Res 1997; 74: 54-60.
14. Gross NT, Nessa K, Camner P, Chinchilla M, Jarstrand C. Interaction between Cryptococcus neoformans and alveolar macrophages. J Med Vet Mycol 1997; 35: 263-269.
15. Nessa K, Gross NT, Jarstrand C, Johansson A, Camner P. In vivo interaction between alveolar macrophages and Cryptococcus neoformans. Mycophatologia 1997; 139: 1-7.
16. Rosen GM, Pou S, Ramos CL, Cohen MS, Britigan BE. Free radicals and phagocytic cells. FASEB J 1995; 9: 200-209.
17. Nyberg K, Nessa K, Johansson A, Jarstrand C, Camner P. Alveolar macrophage response to yeasts and to inert particles. J Med Vet Mycol 1996; 34: 11-17.
18. 15N] nitrate in biological fluids. Anal Biochem 1982; 126: 131-138.
19. Mody CH, Tyler CL, Sitrin CJ, Toews GB. Interferon-γ activates rat alveolar macrophages for anticryptococcal activity. Am J Respir Cell Mol Biol 1991; 5: 19-26.
20. Hed J. The extinction of fluorescence by crystal violet and its use to differentiate between attached and ingested microorganisms in phagocytosis. FEMS Microbiol Lett 1977; 1: 357-361.
21. Levitz SM, DiBenetto DJ. Differential stimulation of murine peritoneal cells by selectively opsonized encapsulated and acapsular Cryptococcus neoformans. Infect Immun 1989; 56: 2522-2551.
22. Sibley LD, Adams LB, Fukotomi Y, Krahenbuhl JL. Tumor necrosis factor-α triggers antitoxoplasmal activity of IFN-γ primed macrophages. J Immunol 1991; 147: 2340-2345.
23. Skerrett SJ, Martin TR. Roles for tumor necrosis factor alpha and nitric oxide in resistance of rat alveolar macrophages to Legionella pneumophila. Inject Immun 1996; 64: 3236-3246.
24. Huffnagle GB, Chen GH, Curtis JL, et al. Down-regulation of the afferent phase of T cell-mediated immunity and pulmonary inflammation by a high melanin-producing strain of C. neoformans. J Immunol 1995; 155: 3507-3516.
25. Alspaugh JA, Granger DL. Inhibition of Cryptococcus neoformans replication by nitrogen oxides supports the role of these molecules as effector of macrophages-mediated cytostasis. Infect Immun 1991; 59: 2291-2296.
26. Gross NT, Chinchilla M, Camner P, Jarstrand C. Anticryptococcal activity by alveolar macrophages from rats treated with cortisone acetate during different periods of time. Mycopathologia 1996; 136: 1-8.